Afatinib
The serum concentration of Afatinib can be increased when it is combined with Abemaciclib.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Abemaciclib.
Apalutamide
The serum concentration of Abemaciclib can be decreased when it is combined with Apalutamide.
Advertisement
Aprepitant
The serum concentration of Abemaciclib can be increased when it is combined with Aprepitant.
Atazanavir
The risk or severity of adverse effects can be increased when Atazanavir is combined with Abemaciclib.
Atomoxetine
The metabolism of Abemaciclib can be decreased when combined with Atomoxetine.
Advertisement
Boceprevir
The risk or severity of adverse effects can be increased when Boceprevir is combined with Abemaciclib.
Bortezomib
The metabolism of Abemaciclib can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Abemaciclib can be decreased when it is combined with Bosentan.
Advertisement
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Abemaciclib.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Abemaciclib.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Abemaciclib.
Carbamazepine
The serum concentration of Abemaciclib can be decreased when it is combined with Carbamazepine.
Ceritinib
The risk or severity of adverse effects can be increased when Ceritinib is combined with Abemaciclib.
Clarithromycin
The risk or severity of adverse effects can be increased when Clarithromycin is combined with Abemaciclib.
Clemastine
The metabolism of Abemaciclib can be decreased when combined with Clemastine.
Clotrimazole
The metabolism of Abemaciclib can be decreased when combined with Clotrimazole.
Cobicistat
The risk or severity of adverse effects can be increased when Cobicistat is combined with Abemaciclib.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Abemaciclib.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Abemaciclib.
Crizotinib
The metabolism of Abemaciclib can be decreased when combined with Crizotinib.
Cyclosporine
The metabolism of Abemaciclib can be decreased when combined with Cyclosporine.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Abemaciclib.
Dabrafenib
The serum concentration of Abemaciclib can be decreased when it is combined with Dabrafenib.
Darunavir
The risk or severity of adverse effects can be increased when Darunavir is combined with Abemaciclib.
Dasatinib
The serum concentration of Abemaciclib can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Abemaciclib can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Abemaciclib can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Abemaciclib can be decreased when combined with Delavirdine.
Dihydroergotamine
The metabolism of Abemaciclib can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Abemaciclib can be decreased when combined with Diltiazem.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Abemaciclib.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Abemaciclib.
Doxycycline
The metabolism of Abemaciclib can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Abemaciclib can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Abemaciclib can be decreased when combined with Dronedarone.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Abemaciclib.
Eltrombopag
The serum concentration of Abemaciclib can be increased when it is combined with Eltrombopag.
Enzalutamide
The serum concentration of Abemaciclib can be decreased when it is combined with Enzalutamide.
Erythromycin
The metabolism of Abemaciclib can be decreased when combined with Erythromycin.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Abemaciclib.
Fluconazole
The metabolism of Abemaciclib can be decreased when combined with Fluconazole.
Fluvoxamine
The metabolism of Abemaciclib can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Abemaciclib can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Abemaciclib can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The serum concentration of Abemaciclib can be decreased when it is combined with Fosphenytoin.
Fusidate
The serum concentration of Abemaciclib can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Abemaciclib can be increased when it is combined with Fusidic Acid.
Hypoxis hemerocallidea root extract
The serum concentration of Abemaciclib can be decreased when it is combined with St. John's Wort.
Idelalisib
The risk or severity of adverse effects can be increased when Idelalisib is combined with Abemaciclib.
Imatinib
The metabolism of Abemaciclib can be decreased when combined with Imatinib.
Indinavir
The risk or severity of adverse effects can be increased when Indinavir is combined with Abemaciclib.
INDINAVIR ANHYDROUS
The risk or severity of adverse effects can be increased when Indinavir is combined with Abemaciclib.
Isavuconazole
The serum concentration of Abemaciclib can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Abemaciclib can be decreased when combined with Isavuconazonium.
Isradipine
The metabolism of Abemaciclib can be decreased when combined with Isradipine.
Itraconazole
The risk or severity of adverse effects can be increased when Itraconazole is combined with Abemaciclib.
Ivacaftor
The serum concentration of Abemaciclib can be increased when it is combined with Ivacaftor.
Ketoconazole
The serum concentration of Abemaciclib can be increased when it is combined with Ketoconazole.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Abemaciclib.
Lopinavir
The risk or severity of adverse effects can be increased when Lopinavir is combined with Abemaciclib.
Lovastatin
The metabolism of Abemaciclib can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Abemaciclib can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Abemaciclib can be decreased when it is combined with Lumacaftor.
Midostaurin
The serum concentration of Abemaciclib can be decreased when it is combined with Midostaurin.
Mifepristone
The serum concentration of Abemaciclib can be increased when it is combined with Mifepristone.
Mitotane
The serum concentration of Abemaciclib can be decreased when it is combined with Mitotane.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Abemaciclib.
Nefazodone
The risk or severity of adverse effects can be increased when Nefazodone is combined with Abemaciclib.
Nelfinavir
The risk or severity of adverse effects can be increased when Nelfinavir is combined with Abemaciclib.
Netupitant
The serum concentration of Abemaciclib can be increased when it is combined with Netupitant.
Nevirapine
The serum concentration of Abemaciclib can be decreased when it is combined with Nevirapine.
Nilotinib
The metabolism of Abemaciclib can be decreased when combined with Nilotinib.
Olaparib
The metabolism of Abemaciclib can be decreased when combined with Olaparib.
Osimertinib
The serum concentration of Abemaciclib can be increased when it is combined with Osimertinib.
Palbociclib
The serum concentration of Abemaciclib can be increased when it is combined with Palbociclib.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Abemaciclib.
Pentobarbital
The serum concentration of Abemaciclib can be decreased when it is combined with Pentobarbital.
Phenobarbital
The serum concentration of Abemaciclib can be decreased when it is combined with Phenobarbital.
Phenytoin
The serum concentration of Abemaciclib can be decreased when it is combined with Phenytoin.
Posaconazole
The risk or severity of adverse effects can be increased when Posaconazole is combined with Abemaciclib.
Primidone
The serum concentration of Abemaciclib can be decreased when it is combined with Primidone.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Abemaciclib.
Rifabutin
The serum concentration of Abemaciclib can be decreased when it is combined with Rifabutin.
Rifampin
The serum concentration of Abemaciclib can be decreased when it is combined with Rifampicin.
Rifapentine
The serum concentration of Abemaciclib can be decreased when it is combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Abemaciclib.
Rolapitant
The serum concentration of Abemaciclib can be increased when it is combined with Rolapitant.
Rucaparib
The metabolism of Abemaciclib can be decreased when combined with Rucaparib.
Saquinavir
The risk or severity of adverse effects can be increased when Saquinavir is combined with Abemaciclib.
Saquinavir Mesylate
The risk or severity of adverse effects can be increased when Saquinavir is combined with Abemaciclib.
Sarilumab
The therapeutic efficacy of Abemaciclib can be decreased when used in combination with Sarilumab.
Sildenafil
The metabolism of Abemaciclib can be decreased when combined with Sildenafil.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Abemaciclib.
Siltuximab
The serum concentration of Abemaciclib can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Abemaciclib can be increased when it is combined with Simeprevir.
ST. JOHN'S WORT EXTRACT
The serum concentration of Abemaciclib can be decreased when it is combined with St. John's Wort.
Sulfisoxazole
The metabolism of Abemaciclib can be decreased when combined with Sulfisoxazole.
Telaprevir
The risk or severity of adverse effects can be increased when Telaprevir is combined with Abemaciclib.
Telithromycin
The risk or severity of adverse effects can be increased when Telithromycin is combined with Abemaciclib.
Teriflunomide
The serum concentration of Abemaciclib can be increased when it is combined with Teriflunomide.
Ticlopidine
The metabolism of Abemaciclib can be decreased when combined with Ticlopidine.
Tocilizumab
The serum concentration of Abemaciclib can be decreased when it is combined with Tocilizumab.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Abemaciclib.
Vemurafenib
The serum concentration of Abemaciclib can be increased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Abemaciclib can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Abemaciclib can be decreased when combined with Verapamil.
Vincristine
The excretion of Vincristine can be decreased when combined with Abemaciclib.
Voriconazole
The risk or severity of adverse effects can be increased when Voriconazole is combined with Abemaciclib.
Ziprasidone
The metabolism of Abemaciclib can be decreased when combined with Ziprasidone.
